Completed
Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
NCT00215202
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +6 more
- Locations
-
- Kentuckiana Cancer Institute PLLC Louisville, Kentucky, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States